Melinta Gets OK For Ch. 11 Equity Swap Plan With Creditor
By Vince Sullivan ( April 2, 2020, 5:33 PM EDT) -- Bankrupt antibiotic developer Melinta Therapeutics received court approval Thursday in Delaware for its proposed Chapter 11 debt-for-equity transaction that will see a secured creditor acquire the reorganized company in exchange for $140 million in debt relief....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.